İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş.
Istanbul pharmaceutical company founded in 1962, headquartered in Kartal, Türkiye. Product lines, financials, customer base, and operational details are not documented in available source material; the company's website returns only a verification loading screen.
- Company typePrivate
- Founded1962
- HeadquartersKartal, Istanbul, Türkiye
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. does
İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. is a Turkish pharmaceutical company headquartered in Kartal, Istanbul, Türkiye, with a founding year of 1962. The legal name translates to "Istanbul Pharmaceutical Industry and Trade Inc." The company operates a website at ii.com.tr, but the site returned only a verification loading screen during data collection, and no product catalog, therapeutic focus areas, manufacturing capacity, regulatory approvals, patents, or trade names could be confirmed.
Beyond basic firmographic data—including a listed headcount of 11 employees, which is unusually small for a pharmaceutical manufacturer and likely reflects a data quality issue—the available source material contains no information about products, services, technology, business model, customers, distribution channels, management team, or financial performance. No public stock ticker, parent company, funding history, mergers, acquisitions, partnerships, awards, or regulatory actions are recorded.
Revenue model, pricing, and go-to-market mechanics are not specified. The company has no identified AI capabilities, no disclosed technology stack, no integrations, and no documented marketing or distribution channels. The overall evidence base is extremely thin, and any assessment beyond the company's name, location, and founding year is limited by the absence of verifiable operational data.
İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. firmographics
Firmographics- Name
- İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş.
- Website
- https://ii.com.tr
- Company type
- Private
- Founded year
- 1962
- Headcount range
- 11–50 employees
- Short description
- Istanbul pharmaceutical company founded in 1962, headquartered in Kartal, Türkiye. Product lines, financials, customer base, and operational details are not documented in available source material; the company's website returns only a verification loading screen.
- Ownership category
- akta.pro rank
İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. industry classification
Industry- Product category
- Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)
- akta.pro secondary industry
- Small-Molecule Analytical Development & Method Validation (CMC) (HLAGAHAF)
Keywords
Where İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. is headquartered
LocationHeadquarters
- HQ city
- Kartal, Istanbul
- HQ country
- Türkiye
- HQ region
- Europe
Markets served
İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. product offering
Product offeringCore offering
İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. appears to operate in the pharmaceutical sector based on its legal name (İlaç = pharmaceutical; Sanayi ve Ticaret = industry and trade). The company is registered in Kartal, Istanbul, Türkiye, with a website at ii.com.tr. The available source material provides only verification/loading page content and does not describe specific products, therapeutic categories, or service lines.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical products
Companies that use İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş.
Customer profileSegments1 record
Ideal customer profiles1 record
İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. competitors and assessment
Company assessmentDirect peers
- Nobel İlaç: Established Turkish pharmaceutical manufacturer with headquarters in Istanbul. Direct peer on the manufacturing/trading of human pharmaceuticals from the same city and regulatory jurisdiction.
- Deva Holding: Istanbul-headquartered Turkish pharmaceutical manufacturer focused on generics, APIs, and human health products. Comparable as a Turkish pharma industry/trading corporate with a similar product overlap.
- Atabay İlaç: Istanbul-based Turkish pharmaceutical manufacturer. Direct regional peer in the same pharma industry/trading segment with overlapping product categories.
- Abdi İbrahim: Türkiye's largest domestic pharmaceutical manufacturer, headquartered in Istanbul. Comparable to İstanbul İlaç Sanayi as a Turkish pharma manufacturer/trader operating under the same 'İlaç Sanayi ve Ticaret' corporate naming convention, and the natural benchmark for what an active Turkish pharma industry entity looks like at scale.
- İlko İlaç: Turkish generics pharma company based in Istanbul. Comparable peer operating in the same national market with the same industry/trading model.
- Eczacıbaşı İlaç (Eczacıbaşı Pharmaceuticals): Istanbul-based Turkish pharmaceutical manufacturer and marketer. Direct comparable on geography, sector, and the 'industry + trade' pharma business model that İstanbul İlaç Sanayi's name implies.
- Sanovel İlaç: Istanbul-based Turkish generic pharmaceutical manufacturer. Comparable to İstanbul İlaç Sanayi in geography, scale aspiration, and finished-dose pharma manufacturing.
Broad incumbents
- Sandoz Türkiye (Novartis): Global generics leader with significant Turkish operations, manufacturing and distributing a broad portfolio of finished-dose and API products in the same regulatory regime as İstanbul İlaç Sanayi.
Market position
Strengths2 records
Weaknesses3 records
Competitive moat1 record
Key risks4 records
Key highlights3 records
Customer concentration
İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. social profiles
Digital presenceİSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. financial estimates
Financial estimateRevenue estimate
Valuation estimate
İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. leadership team
Management profileNumber of profiles
İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş.
What does İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. do?
İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. appears to operate in the pharmaceutical sector based on its legal name (İlaç = pharmaceutical; Sanayi ve Ticaret = industry and trade). The company is registered in Kartal, Istanbul, Türkiye, with a website at ii.com.tr. The available source material provides only verification/loading page content and does not describe specific products, therapeutic categories, or service lines.
When was İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. founded?
İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. was founded in 1962. It employs 11 to 50 people.
Where is İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. based?
İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. is headquartered in Kartal, Istanbul, Türkiye, in the Europe region.
Who are İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş.'s main competitors?
Direct peers on record are Nobel İlaç, Deva Holding, Atabay İlaç, Abdi İbrahim, İlko İlaç, Eczacıbaşı İlaç (Eczacıbaşı Pharmaceuticals) and Sanovel İlaç. Sandoz Türkiye (Novartis) is listed as a broad incumbent.
Does İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. have an API?
No public API is recorded for İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş..
What industry is İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş. in?
İSTANBUL İLAÇ SANAYİ VE TİCARET A.Ş.'s product category is Pharmaceuticals. Its primary akta.pro industry code is HLAIAJAO, Compounding Ingredient & API Distributors (Pharma Supply), with a secondary code of HLAGAHAF, Small-Molecule Analytical Development & Method Validation (CMC). Its NAICS code is 325412 and its SIC code is 2834.